Your browser doesn't support javascript.
loading
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.
Kasikis, Stelios; Baez, Janna; Gandhi, Isha; Grupp, Stephan; Kitko, Carrie L; Kowalyk, Steven; Merli, Pietro; Morales, George; Pulsipher, Michael A; Qayed, Muna; Wölfl, Matthias; Yanik, Gregory; See, Fiona; Hayes, Jack; Grossman, Fred; Burke, Elizabeth; Young, Rachel; Levine, John E; Ferrara, James L M.
Afiliação
  • Kasikis S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Baez J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gandhi I; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Grupp S; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Kitko CL; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kowalyk S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Merli P; Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
  • Morales G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Pulsipher MA; Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Qayed M; Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Wölfl M; Children's Hospital, University of Würzburg, Würzburg, Germany.
  • Yanik G; University of Michigan, Ann Arbor, MI, USA.
  • See F; Mesoblast, Inc., New York, NY, USA.
  • Hayes J; Mesoblast, Inc., New York, NY, USA.
  • Grossman F; Mesoblast, Inc., New York, NY, USA.
  • Burke E; Mesoblast, Inc., New York, NY, USA.
  • Young R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Levine JE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ferrara JLM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. james.ferrara@mssm.edu.
Bone Marrow Transplant ; 56(11): 2869-2870, 2021 11.
Article em En | MEDLINE | ID: mdl-34471240

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article